GlassScriptPhysician profile
Amanda D Wilford
NPI 1508156506
$1,191.56
in general payments reported to CMS, 2019-2025
16 companies · $520 in 2025
The $520 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $158 · 2022: $181 · 2023: $139 · 2024: $193 · 2025: $520.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $853.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $852.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $279.20 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $161.72 | 2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $158.26 | 2025 | Fanapt, Hetlioz |
| Lilly USA, LLC | $136.25 | 2021-2024 | Mounjaro, Zepbound |
| Pfizer INC. | $73.72 | 2021-2025 | |
| Exact Sciences Corporation | $69.58 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $66.72 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $55.48 | 2025 | Breztri |
| Xeris Pharmaceuticals, INC. | $34.58 | 2023-2025 | Gvoke Hypopen |
| Biohaven Pharmaceutical Holding Company LTD. | $31.54 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $29.98 | 2023 | Seglentis, Livalo |
| Medtronic, INC. | $28.93 | 2023 | Interstim |
| Nevro Corp. | $21.43 | 2022 | |
| Novo Nordisk INC | $17.11 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.64 | 2025 | Rexulti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Wilford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.